Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

DNTH

Dianthus Therapeutics (DNTH)

Dianthus Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:DNTH
일자시간출처헤드라인심볼기업
2025/01/3021:00GlobeNewswire Inc.Dianthus Therapeutics to Webcast Presentations at Two Investor ConferencesNASDAQ:DNTHDianthus Therapeutics Inc
2025/01/0821:00GlobeNewswire Inc.Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
2024/11/0806:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
2024/11/0421:00GlobeNewswire Inc.Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor ConferencesNASDAQ:DNTHDianthus Therapeutics Inc
2024/10/1520:00GlobeNewswire Inc.Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual MeetingNASDAQ:DNTHDianthus Therapeutics Inc
2024/09/0420:00GlobeNewswire Inc.Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in SeptemberNASDAQ:DNTHDianthus Therapeutics Inc
2024/08/0905:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
2024/06/2900:30GlobeNewswire Inc.Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)NASDAQ:DNTHDianthus Therapeutics Inc
2024/06/1220:00GlobeNewswire Inc.Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)NASDAQ:DNTHDianthus Therapeutics Inc
2024/05/3105:30GlobeNewswire Inc.Dianthus Therapeutics to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
2024/05/1005:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
2024/05/0905:30GlobeNewswire Inc.Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
2024/05/0405:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
2024/04/1120:30GlobeNewswire Inc.Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual MeetingNASDAQ:DNTHDianthus Therapeutics Inc
2024/04/0605:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
2024/03/2205:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
2024/03/0806:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
2024/02/2621:00GlobeNewswire Inc.Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)NASDAQ:DNTHDianthus Therapeutics Inc
 검색 관련기사 보기:NASDAQ:DNTH